로딩 중…
지수 로딩 중…
Alector, Inc.
ALEC· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$1.75+12.18%
2026-06-18
Price Chart
Alector, Inc.+19.86%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $194M |
| Revenue | $18M |
| Net Income | $-125M |
| Total Assets | $240M |
| Net Assets | $58M |
| Value | |
| P/B | 3.37x |
| P/S | 10.55x |
| FCF Yield | -89.14% |
| Profitability | |
| ROA | -52.26% |
| Op. Margin | -741.33% |
| Revenue Growth | -71.53% |
| Financial Health | |
| Debt Ratio | 397.72% |
| Total Debt | $35M |
| FCF | $-173M |
| Cash | $77M |
| Current Ratio | 5.25x |
| Performance | |
| 1Y Return | 19.86% |
| 1M Return | -17.06% |
| From 52W High | -48.53% |
| 1Y MDD | -65.66% |
| Trading | |
| Volume | 822,075 shares |
| Trading Value | $1M |
| Per Share | |
| EPS | $-1.39 |
| BPS | $0.30 |